Literature DB >> 19937020

The nuss procedure after breast augmentation for female pectus excavatum.

Giovanni Rapuzzi1, Michele Torre, Maria Victoria Romanini, Rosanna Viacava, Nicola Disma, Pier Luigi Santi, Vincenzo Jasonni.   

Abstract

Pectus excavatum, the most common congenital chest wall malformation, has a higher incidence among men. Since 1987, when Donald Nuss performed his technique for the first time, the minimally invasive approach has become the most widely used technique for treating pectus excavatum. Few reported studies have focused on the repair of female pectus excavatum. Women with pectus excavatum often present with breast asymmetry that may require breast augmentation, either before or after pectus excavatum repair. To the authors' knowledge, no reports on the Nuss procedure after breast implant surgery have been published. This report describes the case of a 26-year-old woman who underwent minimally invasive repair after breast implant surgery. The authors believe that for women with severe pectus excavatum, the Nuss procedure should be the first choice for surgical correction. Moreover, for breast implant patients, this technique is absolutely feasible without major complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19937020     DOI: 10.1007/s00266-009-9438-5

Source DB:  PubMed          Journal:  Aesthetic Plast Surg        ISSN: 0364-216X            Impact factor:   2.326


  2 in total

1.  Challenging Breast Augmentations: The Influence of Preoperative Anatomical Features on the Final Result.

Authors:  Yalcin Bayram; Fatih Zor; Huseyin Karagoz; Yalcin Kulahci; Ahmed M Afifi; Serdar Ozturk
Journal:  Aesthet Surg J       Date:  2015-09-29       Impact factor: 4.283

2.  Three-Dimensional Simulation for Breast Augmentation of Female Asymmetric Pectus Excavatum: A Case Report.

Authors:  Yoshichika Yasunaga; Aya Tsuchiya; Yuta Nakajima; Shoji Kondoh; Masahiko Noguchi; Shunsuke Yuzuriha
Journal:  Aesthet Surg J Open Forum       Date:  2019-04-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.